D-Index & Metrics Best Publications

Ralph S. Baric

University of North Carolina at Chapel Hill
United States

Immunology

USA

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Immunology D-index 136 Citations 74,005 499 World Ranking 105 National Ranking 69

Medicine D-index 139 Citations 78,359 519 World Ranking 972 National Ranking 579

Research.com Recognitions

Awards & Achievements

2023 - Research.com Immunology in United States Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

Gene
Virus
DNA

His primary areas of study are Virology, Coronavirus, Virus, Viral replication and Antibody. Ralph S. Baric studies Virology, focusing on Norovirus in particular. The concepts of his Coronavirus study are interwoven with issues in Interferon, Genome, Middle East respiratory syndrome, Coronaviridae and Innate immune system.

His work in Virus tackles topics such as Molecular biology which are related to areas like RNA-dependent RNA polymerase. His Viral replication course of study focuses on RNA and Exon and DNA. Ralph S. Baric combines subjects such as Viral load and Antigen with his study of Antibody.

His most cited work include:

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (2529 citations)
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. (1981 citations)
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking (1067 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Virology, Virus, Coronavirus, Antibody and Viral replication. In his study, Polyclonal antibodies is strongly linked to Monoclonal antibody, which falls under the umbrella field of Virology. His research integrates issues of In vitro and Gene, Virulence in his study of Virus.

His work in Coronavirus addresses issues such as Innate immune system, which are connected to fields such as Interferon. His Antibody study combines topics from a wide range of disciplines, such as Immunity, Antigen and Vaccination. His work in Viral replication addresses subjects such as RNA, which are connected to disciplines such as Molecular biology, Genome and Transcription.

He most often published in these fields:

Virology (66.60%)
Virus (36.54%)
Coronavirus (28.68%)

What were the highlights of his more recent work (between 2018-2021)?

Virology (66.60%)
Antibody (23.38%)
Virus (36.54%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Virology, Antibody, Virus, Coronavirus and Severe acute respiratory syndrome coronavirus 2. His biological study spans a wide range of topics, including In vitro and In vivo. Ralph S. Baric has included themes like Antigen and Immunity in his Antibody study.

His studies in Virus integrate themes in fields like Pandemic, Disease and Immune system. His work deals with themes such as RNA-dependent RNA polymerase, Chimera, Pneumonia, Receptor and Middle East respiratory syndrome, which intersect with Coronavirus. The various areas that Ralph S. Baric examines in his Severe acute respiratory syndrome coronavirus 2 study include Genome and 2019-20 coronavirus outbreak.

Between 2018 and 2021, his most popular works were:

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (2529 citations)
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. (1981 citations)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. (851 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot.
Nature microbiology (2020)

4346 Citations

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

Yushun Wan;Jian Shang;Rachel Graham;Ralph S. Baric.
Journal of Virology (2020)

4203 Citations

Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

Mingxun Wang;Jeremy J Carver;Vanessa V Phelan;Laura M Sanchez.
Nature Biotechnology (2016)

2102 Citations

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer.
Nature Communications (2020)

1757 Citations

Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot.
bioRxiv (2020)

1671 Citations

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery.
Science Translational Medicine (2017)

1454 Citations

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.

Raoul J. de Groot;Susan C. Baker;Ralph S. Baric;Caroline S. Brown.
Journal of Virology (2013)

1362 Citations

Norwalk Virus: How Infectious Is It?

Peter F.M. Teunis;Christine L. Moe;Pengbo Liu;Sara E. Miller.
Journal of Medical Virology (2008)

1276 Citations

Human susceptibility and resistance to Norwalk virus infection

Lisa Lindesmith;Christine Moe;Severine Marionneau;Nathalie Ruvoen.
Nature Medicine (2003)

1211 Citations

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini;Erica L. Andres;Amy C Sims;Rachel Lauren Graham.
Mbio (2018)

1129 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Ralph S. Baric